Tandem Diabetes Care, Inc. (TNDM) Financials
TNDM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 941.0 million | 698.0 million |
2023-12-31 | 952.7 million | 639.0 million |
2023-09-30 | 939.9 million | 625.9 million |
2023-06-30 | 946.7 million | 617.4 million |
TNDM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -12.5 million | 22.0 million |
2023-12-31 | -34.7 million | 22.7 million |
2023-09-30 | -5.3 million | 20.7 million |
2023-06-30 | -16.2 million | 23.4 million |
TNDM Net Income
No data available :(
TNDM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 467.8 million | - | 130.1 million |
2023-12-31 | 467.9 million | - | 130.6 million |
2023-09-30 | 498.2 million | - | 133.6 million |
2023-06-30 | 507.2 million | - | 136.2 million |
TNDM Shares Outstanding
TNDM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 4.5 million | 46.2 million | 90.1 million | - |
2023-12-31 | 27.5 million | 42.6 million | 85.8 million | - |
2023-09-30 | 5.4 million | 42.0 million | 79.3 million | - |
2023-06-30 | 9.9 million | 42.9 million | 97.6 million | - |
TNDM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 191.7 million | 97.0 million |
2023-12-31 | 196.8 million | 103.5 million |
2023-09-30 | 185.6 million | 95.9 million |
2023-06-30 | 195.9 million | 94.2 million |
TNDM
Price: $47.30
52 week price:
Earnings Per Share: -3.43 USD
P/E Ratio: -7.26
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Volume: 448000
Ebitda: -11.4 millionMarket Capitalization: 2.8 billion